Since the P2Y2 receptor and the KCa3.1 channel are co-expressed in neoplastic cells from human ovary, we propose that they may be useful tumor markers as well as targets for therapy to halt ovarian cancer progression. The gene discussed is KCNN4; the disease is ovarian cancer.